Skip to main content

Table 2 Prevalence of LS stage 2 and LS based on each of the three LS risk tests and total assessment

From: Improvement of locomotive syndrome with surgical treatment in patients with degenerative diseases in the lumbar spine and lower extremities: a prospective cohort study

Groups

Total

(n = 257)

Lumbar

(n = 81)

Hip

(n = 106)

Knee

(n = 43)

Foot & Ankle

(n = 27)

Total assessment: prevalence of LS stage 2, % (that of LS [LS stage 1 and 2], %)

 Before surgery

94.9 (100)

95.1 (100)

95.3 (100)

100 (100)

85.2 (100)

 6 months after surgery

63.0 (97.7)

59.3 (96.3)

55.7 (98.1)

88.4 (100)

63.0 (96.3)

 12 months after surgery

56.8 (94.6)

54.3 (97.5)

46.2 (90.6)

90.7 (100)

51.9 (92.6)

Stand-up test: prevalence of LS stage 2, % (that of LS [LS stage 1 and 2], %)

 Before surgery

47.5 (84.4)

21.0 (79.0)

60.4 (87.7)

83.7 (93.0)

18.5 (74.1)

 6 months after surgery

36.2 (86.4)

22.2 (86.4)

33.0 (86.8)

86.0 (95.3)

11.1 (70.4)

 12 months after surgery

33.5 (80.9)

17.3 (79.0)

30.2 (77.4)

86.0 (97.7)

11.1 (74.1)

Two-step test: prevalence of LS stage 2, % (that of LS [LS stage 1 and 2], %)

 Before surgery

58.8 (89.9)

44.4 (79.0)

71.7 (96.2)

76.7 (95.3)

22.2 (74.1)

 6 months after surgery

39.3 (76.7)

37.0 (67.9)

37.7 (79.2)

53.5 (83.7)

29.6 (81.5)

 12 months after surgery

31.1 (69.3)

28.4 (61.7)

29.2 (69.8)

53.5 (86.0)

11.1 (63.0)

GLFS-25: prevalence of LS stage 2, % (that of LS [LS stage 1 and 2], %)

 Before surgery

90.3 (99.6)

92.6 (100)

91.5 (100)

93.0 (100)

74.1 (96.3)

 6 months after surgery

43.6 (77.8)

46.9 (77.8)

33.0 (69.8)

60.5 (93.0)

48.1 (85.2)

 12 months after surgery

39.7 (75.9)

45.7 (84.0)

28.3 (62.3)

53.5 (90.7)

44.4 (81.5)

  1. GLFD-25 25-Question Geriatric Locomotive Function Scale; LS locomotive syndrome